SUN PHARMA INDUSTRIES: Q3 EBITDA 34.8B RUPEES VS 30B (YOY); EST 31.97B || Q3 EBITDA MARGIN 28.08% VS 26.7% (YOY); EST 26.2%

SUN PHARMA INDUSTRIES: Q3 EBITDA GROWTH OF 16.00% AND 8.85% ABOVE ESTIMATION

BEAT YOY
INLINE ESTIMATES